These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4152816)

  • 1. Compartmentation of dopamine in rat striatum.
    Doteuchi M; Wang C; Costa E
    Mol Pharmacol; 1974 Mar; 10(2):225-34. PubMed ID: 4152816
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dibutyryl cyclic adenosine monophosphate on 14C-dopamine biosynthesis in rat brain striatal slices.
    Anagnoste B; Shirron C; Friedman E; Goldstein M
    J Pharmacol Exp Ther; 1974 Dec; 191(3):370-6. PubMed ID: 4154377
    [No Abstract]   [Full Text] [Related]  

  • 3. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat.
    Uretsky NJ
    J Pharmacol Exp Ther; 1974 May; 189(2):359-69. PubMed ID: 4829219
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin.
    Kettler R; Bartholini G; Pletscher A
    Nature; 1974 May; 249(456):476-8. PubMed ID: 4834235
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of some psychotropic drugs on dopamine synthesis in the rat striatum.
    Besson MJ; Cheramy A; Glowinski J
    J Pharmacol Exp Ther; 1971 Apr; 177(1):196-205. PubMed ID: 4398047
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.
    Gerhards HJ; Carenzi A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):49-63. PubMed ID: 4375258
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
    Tseng LF; Hitzemann RJ; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract]   [Full Text] [Related]  

  • 10. Some aspects of dopamine in the central nervous system.
    Carlsson A
    Adv Neurol; 1974; 5():59-68. PubMed ID: 4155236
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum.
    Bariletto S; Dollar E; Leitz F
    J Neurochem; 1975 Aug; 25(2):139-42. PubMed ID: 1141911
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of alpha-methyltyrosine on d-amphetamine-induced release of endogenously synthesized and exogenously administered catecholamines from the cat brain in vivo.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1974 Jul; 190(1):100-8. PubMed ID: 4847307
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification by methyltyrosine methylester (H 44-68) of the amphetamine-induced toxicity and brain catecholamine changes in developing mice.
    Alhava E
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):119-28. PubMed ID: 4741031
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: The effect of delta-tetrahydrocannabinol (delta-thc) on dopamine metabolism in the rat corpus striatum: the influence of environment.
    Littleton JM; Maclean KI
    Br J Pharmacol; 1974 May; 51(1):117P. PubMed ID: 4441767
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term depression in striatal dopamine release monitored by in vivo voltammetry in free moving rats.
    Abraini JH; Raharison L; Rostain JC
    Brain Res; 1991 May; 548(1-2):256-9. PubMed ID: 1678298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 17. Short- and long-term regulation of tyrosine hydroxylase.
    Costa E; Guidotti A; Zivkovic B
    Adv Biochem Psychopharmacol; 1974; 12(0):161-75. PubMed ID: 4154019
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
    Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic regulation of tyrosine hydroxylase activity in rat striatal synaptosomes by dopamine analogs.
    Waggoner WG; McDermed J; Leighton HJ
    Mol Pharmacol; 1980 Jul; 18(1):91-9. PubMed ID: 6106156
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.